Soticlestat

3 trials Orphan designation

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

1 Sponsors

12 Countries

Phase III

Phase II

Phase III: 2 Phase II: 1

Indications tested

Lennox-Gastaut syndrome 3 CDKL5 deficiency disorder 1

Sponsors using this IMP

Takeda Development Center Americas Inc. 3

All trials

3 total

Study About the Safety of Soticlestat and if it can Help Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome who Have Alread… Ended

2023-504104-29-00 Phase III 1 country Takeda Development Center Americas Inc.
Open-label extesnion study of soticlestat in Dravet and Lennox-Gastaut Syndromes Ended

2022-502802-34-00 Phase III 10 countries Takeda Development Center Americas Inc.
Open-label Follow-up Study of Soticlestat in Adults and Children with Developmental Epileptic Encephalopathies Ended

2022-502801-13-00 Phase II 3 countries Takeda Development Center Americas Inc.

Showing 1–3 of 3 trials

← All drugs A–Z